IMS 2022 | The importance of shared decision making in multiple myeloma
Beth Faiman
• 26 Aug 2022
Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, Cleveland Clinic, Cleveland, OH, emphasizes the importance of shared decision-making in multiple myeloma. Studies have shown that shared decision-making leads to better adherence to therapy and an improved relationship between HCPs and patients, which may lead to better patient outcomes. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
